Page last updated: 2024-08-23

piperacillin and Inflammatory Response Syndrome, Systemic

piperacillin has been researched along with Inflammatory Response Syndrome, Systemic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garland, JL; Lewis, JI; Squier, SB1
Capparelli, FJ; Del Castillo, ME; Diaz, MF; Hlavnika, A; Leiguarda, R; Wainsztein, NA1

Other Studies

2 other study(ies) available for piperacillin and Inflammatory Response Syndrome, Systemic

ArticleYear
63-Year-Old Woman With Generalized Fatigue and Left Flank Pain.
    Mayo Clinic proceedings, 2015, Volume: 90, Issue:10

    Topics: Acute Disease; Anti-Bacterial Agents; Catheterization, Central Venous; Diagnosis, Differential; Drug Administration Routes; Escherichia coli; Fatigue; Female; Flank Pain; Fluid Therapy; Humans; Levofloxacin; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Systemic Inflammatory Response Syndrome; Tomography, X-Ray Computed; Treatment Outcome

2015
Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function.
    Neurology, 2005, Dec-13, Volume: 65, Issue:11

    Topics: Aged, 80 and over; Anti-Bacterial Agents; Brain; Cefepime; Cefixime; Cephalosporins; Confusion; Consciousness Disorders; Delirium; Epididymitis; Humans; Kidney; Male; Metabolic Clearance Rate; Neurotoxicity Syndromes; Penicillanic Acid; Piperacillin; Recovery of Function; Secondary Prevention; Systemic Inflammatory Response Syndrome; Tazobactam; Urinary Tract Infections; Withholding Treatment

2005